Key facts
- Lumata Health’s last known valuation is $54.8M (Jan 2025).
- It has raised $35.7M across 3 recorded rounds; the latest was Early Stage VC ($23.3M) in Jan 2025.
- Notable investors include Triangle Tweener Fund, Cortado Ventures, McKesson Ventures, Boyd Street Ventures, Cencora — 8 tracked in total.
- Lumata Health has filed 4 Form Ds with the SEC since 2022, most recently Feb 2025 ($23.3M sold to 40 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Lumata Health
Funding rounds
3 roundsAbout Lumata Health
Operator of an ophthalmology care management platform intended to help people recover from blindness. The company's platform identifies and removes the complex barriers to treatment adherence that contribute to vision loss from chronic eye conditions like glaucoma, diabetic retinopathy, and macular degeneration, by acting as a remote extension of the in-clinic staff, enabling patients to recover from chronic eye care.
- Sector
- Healthcare
- HQ
- Oklahoma City, OK, United States
- Founded
- 2017
- Employees
- 82
- Website
- lumatahealth.com/
- Ownership
- Privately Held (backing)
Lumata Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lumata Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lumata Health in its N-PORT filings yet. We sweep new filings monthly.